In contrast, low LC3B expression was more frequently detected among patients who underwent complete tumor resection (24/31; 77.4%), whereas high LC3B expression was more prevalent in patients with incomplete resection and biopsy (68.4% and 63.6%, respectively). Here, MAP1LC3B is linked to neoplasm.